Citizens Financial Group Inc Vertex Pharmaceuticals Inc Transaction History

Citizens Financial Group Inc

$4.91 Billion
Q3 2024

A detailed history of Citizens Financial Group Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Citizens Financial Group Inc holds 22,117 shares of VRTX stock, worth $11.1 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

22,117

Previous 29,473 24.96%

Holding current value

$11.1 Million

Previous $13.8 Million 25.54%

% of portfolio

0.21%

Previous 0.31%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$460.0 - $505.78 $3.38 Million - $3.72 Million	-7,356 Reduced 24.96%	22,117 $10.3 Million
Q2 2024 Aug 09, 2024	BUY	$392.81 - $485.53 $38,888 - $48,067	99 Added 0.34%	29,473 $13.8 Million
Q1 2024 May 17, 2024	SELL	$407.69 - $446.08 $172,045 - $188,245	-422 Reduced 1.42%	29,374 $12.3 Million
Q4 2023 Feb 02, 2024	SELL	$343.0 - $410.68 $110,789 - $132,649	-323 Reduced 1.07%	29,796 $12.1 Million
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $508,284 - $544,777	-1,503 Reduced 4.75%	30,119 $10.5 Million
Q2 2023 Aug 04, 2023	SELL	$314.42 - $351.91 $3.63 Million - $4.07 Million	-11,557 Reduced 26.77%	31,622 $11.1 Million
Q1 2023 May 10, 2023	SELL	$283.23 - $323.1 $212,705 - $242,648	-751 Reduced 1.71%	43,179 $13.6 Million
Q4 2022 Feb 09, 2023	SELL	$285.76 - $321.48 $505,795 - $569,019	-1,770 Reduced 3.87%	43,930 $12.7 Million
Q3 2022 Nov 10, 2022	BUY	$273.83 - $305.53 $60,790 - $67,827	222 Added 0.49%	45,700 $13.2 Million
Q2 2022 Aug 05, 2022	SELL	$234.96 - $292.55 $566,488 - $705,338	-2,411 Reduced 5.03%	45,478 $12.8 Million
Q1 2022 May 12, 2022	BUY	$221.42 - $260.97 $86,132 - $101,517	389 Added 0.82%	47,889 $12.5 Million
Q4 2021 Feb 10, 2022	BUY	$177.01 - $223.45 $7.61 Million - $9.61 Million	42,987 Added 952.51%	47,500 $10.4 Million
Q3 2021 Nov 05, 2021	BUY	$181.39 - $202.99 $818,613 - $916,093	4,513 New	4,513 $819,000
Q3 2020 Nov 12, 2020	SELL	$255.65 - $303.1 $144,442 - $171,251	-565 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$225.48 - $295.8 $9,470 - $12,423	-42 Reduced 6.92%	565 $164,000
Q1 2020 May 08, 2020	SELL	$199.77 - $247.81 $11,586 - $14,372	-58 Reduced 8.72%	607 $144,000
Q4 2019 Feb 07, 2020	BUY	$166.71 - $223.91 $64,850 - $87,100	389 Added 140.94%	665 $146,000
Q3 2019 Nov 01, 2019	BUY	$166.23 - $187.09 $29,921 - $33,676	180 Added 187.5%	276 $47,000
Q2 2019 Aug 09, 2019	BUY	$164.61 - $190.37 $6,584 - $7,614	40 Added 71.43%	96 $17,000
Q1 2019 May 09, 2019	SELL	$163.73 - $194.7 $4,093 - $4,867	-25 Reduced 30.86%	56 $10,000
Q1 2018 May 11, 2018	BUY	$151.6 - $177.13 $12,279 - $14,347	81 New	81 $13,000

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citizens Financial Group Inc with notifications on news.

Account

Citizens Financial Group Inc Vertex Pharmaceuticals Inc Transaction History